Beneficient (NASDAQ:BENF – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 107,656 shares, a decline of 22.6% from the December 31st total of 139,093 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average daily volume of 57,662 shares, the days-to-cover ratio is presently 1.9 days. Based on an average daily volume of 57,662 shares, the days-to-cover ratio is presently 1.9 days. Approximately 0.8% of the company’s shares are short sold.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on BENF shares. Wall Street Zen raised shares of Beneficient to a “sell” rating in a research report on Saturday, November 1st. Weiss Ratings restated a “sell (e+)” rating on shares of Beneficient in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.
Read Our Latest Research Report on BENF
Beneficient Stock Down 2.3%
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
Read More
- Five stocks we like better than Beneficient
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Gold’s getting scarce.
- Trump’s Final Shocking Act Begins February 24
- The Number One Way to Play Gold
- NEW: Gold makes history
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
